Premium
Imiquimod 5% cream for the treatment of nasal lesion of metastatic renal cell carcinoma
Author(s) -
ASAKURA MAKIKO,
MIURA HIROYUKI
Publication year - 2011
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/j.1529-8019.2011.01423.x
Subject(s) - imiquimod , medicine , lesion , renal cell carcinoma , nose , nephrectomy , dermatology , carcinoma , metastasis , pathology , kidney , surgery , cancer
Many reports have shown the efficacy of topical imiquimod in patients with skin carcinoma. This effect is based on the activity of imiquimod as an immune‐response modifier. The present authors hypothesized that this agent could also be used to treat skin metastatic lesion from renal cell carcinoma. The present authors report the case of a 54‐year‐old man who presented with a metastasis renal cell carcinoma lesion on his nose. He had a history of right nephrectomy performed 4 years previously. The present authors started him on topical treatment with imiquimod 5% cream three times a week for his nose lesion. A reduction of the lesion was observed after 2 months, and during the following 12 months no sign of recurrence was observed.